content/01.abstract.md:5:bradykinesia
content/01.abstract.md:5:exosomes
content/01.abstract.md:5:exosomes
content/01.abstract.md:5:intracellular
content/01.abstract.md:5:LBD
content/01.abstract.md:5:LBD
content/01.abstract.md:5:Lewy
content/01.abstract.md:5:misfolded
content/01.abstract.md:5:misfolded
content/01.abstract.md:5:MSA
content/01.abstract.md:5:MSA
content/01.abstract.md:5:parkinsonian
content/01.abstract.md:5:pathologies
content/01.abstract.md:5:PSP
content/01.abstract.md:5:PSP
content/01.abstract.md:5:Supranuclear
content/01.abstract.md:5:synuclein
content/02.body-document.md:3:Charcot
content/02.body-document.md:3:Charcot
content/02.body-document.md:3:Dejerine
content/02.body-document.md:3:Friedrich
content/02.body-document.md:3:intraneuronal
content/02.body-document.md:3:Lewy
content/02.body-document.md:3:Lewy
content/02.body-document.md:3:Maladie
content/02.body-document.md:3:misfolded
content/02.body-document.md:3:MSA
content/02.body-document.md:3:MSA
content/02.body-document.md:3:nigra
content/02.body-document.md:3:substantia
content/02.body-document.md:3:synuclein
content/02.body-document.md:5:Arvid
content/02.body-document.md:5:carbidopa
content/02.body-document.md:5:Carlsson
content/02.body-document.md:5:dopaminergic
content/02.body-document.md:5:levodopa
content/02.body-document.md:5:Lewy
content/02.body-document.md:5:misfolded
content/02.body-document.md:5:MPTP
content/02.body-document.md:5:MSA
content/02.body-document.md:5:SNCA
content/02.body-document.md:5:synuclein
content/02.body-document.md:5:synuclein
content/02.body-document.md:7:Braak
content/02.body-document.md:7:dysregulation
content/02.body-document.md:7:Filip
content/02.body-document.md:7:Heiko
content/02.body-document.md:7:hypotension
content/02.body-document.md:7:microbiota
content/02.body-document.md:7:misfolded
content/02.body-document.md:7:misfolding
content/02.body-document.md:7:MSA
content/02.body-document.md:7:MSA
content/02.body-document.md:7:neurodegeneration
content/02.body-document.md:7:orthostatic
content/02.body-document.md:7:prodromal
content/02.body-document.md:7:reframed
content/02.body-document.md:7:Scheperjans
content/02.body-document.md:7:synuclein
content/02.body-document.md:7:synuclein
content/02.body-document.md:7:synuclein
content/02.body-document.md:11:Braak
content/02.body-document.md:11:Braak’s
content/02.body-document.md:11:Lewy
content/02.body-document.md:11:Lewy’s
content/02.body-document.md:11:microbiome
content/02.body-document.md:11:MSA
content/02.body-document.md:11:MSA
content/02.body-document.md:11:prodromal
content/02.body-document.md:11:synuclein
content/02.body-document.md:13:Pathogenesis
content/02.body-document.md:15:Braak
content/02.body-document.md:15:Braak
content/02.body-document.md:15:Braak’s
content/02.body-document.md:15:Braak’s
content/02.body-document.md:15:glia
content/02.body-document.md:15:microbiota
content/02.body-document.md:15:Misfolded
content/02.body-document.md:15:misfolding
content/02.body-document.md:15:MSA
content/02.body-document.md:15:mucosa
content/02.body-document.md:15:reframed
content/02.body-document.md:15:synuclein
content/02.body-document.md:17:Microbiome
content/02.body-document.md:19:dendritic
content/02.body-document.md:19:dipeptide
content/02.body-document.md:19:dysbiosis
content/02.body-document.md:19:dysbiosis
content/02.body-document.md:19:dysbiosis
content/02.body-document.md:19:EVs
content/02.body-document.md:19:glial
content/02.body-document.md:19:immunogenic
content/02.body-document.md:19:immunogenic
content/02.body-document.md:19:intracellular
content/02.body-document.md:19:lipopolysaccharide
content/02.body-document.md:19:LPS
content/02.body-document.md:19:LPS
content/02.body-document.md:19:MDP
content/02.body-document.md:19:MDP
content/02.body-document.md:19:MSA
content/02.body-document.md:19:MSA
content/02.body-document.md:19:muramyl
content/02.body-document.md:19:neurodegenerative
content/02.body-document.md:19:Oligomerization
content/02.body-document.md:19:overrepresentation
content/02.body-document.md:19:peptidoglycan
content/02.body-document.md:19:peptidoglycans
content/02.body-document.md:19:peptidoglycans
content/02.body-document.md:19:PGNs
content/02.body-document.md:19:PGNs
content/02.body-document.md:19:stimulator
content/02.body-document.md:21:cytosol
content/02.body-document.md:21:dipeptide
content/02.body-document.md:21:dysbiosis
content/02.body-document.md:21:endocytosed
content/02.body-document.md:21:EVs
content/02.body-document.md:21:EVs
content/02.body-document.md:21:immunogenic
content/02.body-document.md:21:LPS
content/02.body-document.md:21:MDP
content/02.body-document.md:21:muramyl
content/02.body-document.md:21:pathogenesis
content/02.body-document.md:21:peptidoglycan
content/02.body-document.md:23:dendritic
content/02.body-document.md:23:glial
content/02.body-document.md:23:LPS
content/02.body-document.md:23:MDP
content/02.body-document.md:23:microbiome
content/02.body-document.md:23:microbiota
content/02.body-document.md:23:propria
content/02.body-document.md:23:propria
content/02.body-document.md:25:axonal
content/02.body-document.md:25:dopaminergic
content/02.body-document.md:25:dopaminergic
content/02.body-document.md:25:dopaminergic
content/02.body-document.md:25:glial
content/02.body-document.md:25:pathogenesis
content/02.body-document.md:25:propria
content/02.body-document.md:25:submucosal
content/02.body-document.md:25:synuclein
content/02.body-document.md:25:synucleinopathies
content/02.body-document.md:25:unmyelinated
content/02.body-document.md:25:unmyelination
content/02.body-document.md:30:dopaminergic
content/02.body-document.md:30:MSA
content/02.body-document.md:30:MSA
content/02.body-document.md:30:neurodegenerative
content/02.body-document.md:30:pathogenesis
content/02.body-document.md:30:PNS
content/02.body-document.md:30:PNS
content/02.body-document.md:30:synuclein
content/02.body-document.md:30:synucleinopathies
content/02.body-document.md:32:MSA
content/02.body-document.md:32:synucleinopathies
content/02.body-document.md:38:PNS
content/02.body-document.md:39:glial
content/02.body-document.md:39:myenteric
content/02.body-document.md:39:submucosal
content/02.body-document.md:39:unmyelinated
content/02.body-document.md:39:unmyelinated
content/02.body-document.md:41:Braak
content/02.body-document.md:41:Braak's
content/02.body-document.md:41:misfolded
content/02.body-document.md:41:MSA
content/02.body-document.md:41:synuclein
content/02.body-document.md:41:synucleinopathies
content/02.body-document.md:43:PNS
content/02.body-document.md:45:axonal
content/02.body-document.md:45:MSA
content/02.body-document.md:45:myelinated
content/02.body-document.md:45:PNS
content/02.body-document.md:45:PNS
content/02.body-document.md:45:prodromal
content/02.body-document.md:45:Schwann
content/02.body-document.md:45:synuclein
content/02.body-document.md:47:hypotension
content/02.body-document.md:47:MSA
content/02.body-document.md:47:MSA
content/02.body-document.md:47:orthostatic
content/02.body-document.md:47:PNS
content/02.body-document.md:49:hypotension
content/02.body-document.md:49:MSA
content/02.body-document.md:49:MSA
content/02.body-document.md:49:orthostatic
content/02.body-document.md:49:PNS
content/02.body-document.md:53:dopaminergic
content/02.body-document.md:53:dopaminergic
content/02.body-document.md:53:GABAergic
content/02.body-document.md:53:glial
content/02.body-document.md:53:interconnectivity
content/02.body-document.md:53:misfolded
content/02.body-document.md:53:MSA
content/02.body-document.md:53:myelinate
content/02.body-document.md:53:myelinated
content/02.body-document.md:53:nigra
content/02.body-document.md:53:oligodendrocyte
content/02.body-document.md:53:oligodendrocytes
content/02.body-document.md:53:oligodendrocytes
content/02.body-document.md:53:serotonergic
content/02.body-document.md:53:substantia
content/02.body-document.md:53:synuclein
content/02.body-document.md:55:axonal
content/02.body-document.md:55:cholinergic
content/02.body-document.md:55:demyelination
content/02.body-document.md:55:dopaminergic
content/02.body-document.md:55:MSA
content/02.body-document.md:55:MSA
content/02.body-document.md:55:multisystem
content/02.body-document.md:55:myelin
content/02.body-document.md:55:oligodendrocytes
content/02.body-document.md:55:serotonergic
content/02.body-document.md:65:CSF
content/02.body-document.md:65:DLB
content/02.body-document.md:65:MSA
content/02.body-document.md:65:Oligomers
content/02.body-document.md:65:Synuclein
content/02.body-document.md:66:CSF
content/02.body-document.md:66:DLB
content/02.body-document.md:66:MSA
content/02.body-document.md:66:Synuclein
content/02.body-document.md:67:CSF
content/02.body-document.md:67:Phosphorylated
content/02.body-document.md:67:Synuclein
content/02.body-document.md:68:CBD
content/02.body-document.md:68:CSF
content/02.body-document.md:68:MSA
content/02.body-document.md:68:Neurofilament
content/02.body-document.md:68:PSP
content/02.body-document.md:69:CSF
content/02.body-document.md:69:DLB
content/02.body-document.md:69:MSA
content/02.body-document.md:70:CSF
content/02.body-document.md:70:DLB
content/02.body-document.md:70:Phosphorylated
content/02.body-document.md:71:CSF
content/02.body-document.md:71:DLB
content/02.body-document.md:72:CSF
content/02.body-document.md:73:CSF
content/02.body-document.md:73:MSA
content/02.body-document.md:74:CBD
content/02.body-document.md:74:CSF
content/02.body-document.md:74:MSA
content/02.body-document.md:74:PSP
content/02.body-document.md:74:TNF
content/02.body-document.md:75:CSF
content/02.body-document.md:75:MicroRNAs
content/02.body-document.md:76:CSF
content/02.body-document.md:76:MSA
content/02.body-document.md:76:Parkin
content/02.body-document.md:77:CSF
content/02.body-document.md:77:MSA
content/02.body-document.md:80:CBD
content/02.body-document.md:80:Corticobasal
content/02.body-document.md:80:DLB
content/02.body-document.md:80:Lewy
content/02.body-document.md:80:MSA
content/02.body-document.md:80:PSP
content/02.body-document.md:80:Supranuclear
content/02.body-document.md:82:Exosomes
content/02.body-document.md:84:Exosomes
content/02.body-document.md:86:exosome
content/02.body-document.md:86:exosomes
content/02.body-document.md:86:neurodegeneration
content/02.body-document.md:86:neurodegenerative
content/02.body-document.md:86:prodromal
content/02.body-document.md:88:exosomes
content/02.body-document.md:88:exosomes
content/02.body-document.md:88:exosomes
content/02.body-document.md:88:exosomes
content/02.body-document.md:88:microRNA
content/02.body-document.md:88:misfolded
content/02.body-document.md:88:neurodegenerative
content/02.body-document.md:88:neurodegenerative
content/02.body-document.md:88:neuroinflammation
content/02.body-document.md:90:concentrators
content/02.body-document.md:90:dopaminergic
content/02.body-document.md:90:exosome
content/02.body-document.md:90:exosomes
content/02.body-document.md:90:exosomes
content/02.body-document.md:90:exosomes
content/02.body-document.md:90:exosomes
content/02.body-document.md:90:neurodegenerative
content/02.body-document.md:90:oligodendrocytes
content/02.body-document.md:92:Exosomes
content/02.body-document.md:96:Translational
content/02.body-document.md:98:levodopa
content/02.body-document.md:98:MSA
content/02.body-document.md:98:MSA
content/02.body-document.md:98:MSA
content/02.body-document.md:100:axonal
content/02.body-document.md:100:demyelination
content/02.body-document.md:100:glial
content/02.body-document.md:100:MSA
content/02.body-document.md:100:MSA
content/02.body-document.md:100:oligodendrocyte
content/02.body-document.md:100:pathologies
content/02.body-document.md:100:preclinical
content/02.body-document.md:100:remyelination
content/02.body-document.md:100:repurposing
content/02.body-document.md:102:demyelinating
content/02.body-document.md:102:MSA
content/02.body-document.md:102:MSA
content/02.body-document.md:102:myeloma
content/02.body-document.md:149:adipiscing
content/02.body-document.md:149:aliqua
content/02.body-document.md:149:amet
content/02.body-document.md:149:consectetur
content/02.body-document.md:149:dolore
content/02.body-document.md:149:eiusmod
content/02.body-document.md:149:elit
content/02.body-document.md:149:incididunt
content/02.body-document.md:149:ipsum
content/02.body-document.md:149:labore
content/02.body-document.md:149:Lorem
content/02.body-document.md:149:magna
content/02.body-document.md:149:sed
content/02.body-document.md:149:tempor
content/02.body-document.md:150:aliquip
content/02.body-document.md:150:commodo
content/02.body-document.md:150:consequat
content/02.body-document.md:150:enim
content/02.body-document.md:150:exercitation
content/02.body-document.md:150:laboris
content/02.body-document.md:150:nisi
content/02.body-document.md:150:nostrud
content/02.body-document.md:150:quis
content/02.body-document.md:150:ullamco
content/02.body-document.md:150:veniam
content/02.body-document.md:151:aute
content/02.body-document.md:151:cillum
content/02.body-document.md:151:dolore
content/02.body-document.md:151:Duis
content/02.body-document.md:151:esse
content/02.body-document.md:151:fugiat
content/02.body-document.md:151:irure
content/02.body-document.md:151:pariatur
content/02.body-document.md:151:reprehenderit
content/02.body-document.md:151:velit
content/02.body-document.md:151:voluptate
content/02.body-document.md:152:anim
content/02.body-document.md:152:culpa
content/02.body-document.md:152:cupidatat
content/02.body-document.md:152:deserunt
content/02.body-document.md:152:Excepteur
content/02.body-document.md:152:laborum
content/02.body-document.md:152:mollit
content/02.body-document.md:152:occaecat
content/02.body-document.md:152:officia
content/02.body-document.md:152:proident
content/02.body-document.md:152:qui
content/02.body-document.md:152:sint
content/02.body-document.md:152:sunt
content/02.body-document.md:342:Pandoc's
content/02.body-document.md:352:Pandoc's
